We use biochemical innovation to design and generate superior ADCs. Our genetic code expansion technology allows to engineer conjugation sites anywhere in the antibody with genetic precision. These sites can then be conjugated with our proprietary payloads via our highly efficient click chemistry. This process yields highly efficacious, uniform and safe ADCs while reducing production steps, time and costs.
Evolution of cancer therapies towards potent target specific-drugs
Functional antibody screening
Our proprietary microfluidic platform combines single-cell analysis with droplet-based microfluidic sorting to identify functional antibodies against a broad spectrum of targets.Learn more